Zura Bio
ZURA
17 hedge funds and large institutions have $27.9M invested in Zura Bio in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$11.7M |
| 2 |
BGIM
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
+$3.68M |
| 3 |
SCC
Spring Creek Capital
Wichita,
Kansas
|
+$2.94M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$2.46M |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$2.45M |
Top Sellers
ZURA Hedge Fund Activity: Q3 2021 in Review
17 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2021, worth a combined $27.9M.
Buyers outnumbered sellers: 17 funds opened new ZURA positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $11.7M.
- 17 institutional investors held Zura Bio (ZURA) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $27.9M of Zura Bio stock for Q3 2021.
- 17 funds opened new Zura Bio positions in Q3 2021 and 0 closed out, a net change of +17 holders.
- The largest Zura Bio buyer in Q3 2021 was Hudson Bay Capital Management, an estimated $11.7M added.
Based on aggregated 13F filings for Q3 2021.